Publications by authors named "Claudia L Charles-Nino"

Article Synopsis
  • Cryptococcus neoformans (Cn) is a dangerous fungus that can lead to severe brain infections, especially in people with weakened immune systems; the study explores the role of the cytokine IL-6 in fighting this infection.* -
  • Mice lacking IL-6 (knock-out) showed increased mortality and higher fungal levels in the brain and blood compared to wild-type and IL-6 supplemented groups, indicating IL-6's importance in controlling Cn infection.* -
  • The presence of IL-6 led to a stronger immune response in the brain, characterized by activated microglia that help fight off the fungus, while its absence resulted in fewer defensive responses and potential neurodegeneration.*
View Article and Find Full Text PDF

Cryptococcus neoformans (Cn) is an opportunistic fungus that causes severe central nervous system (CNS) disease in immunocompromised individuals. Brain parenchyma invasion requires fungal traversal of the blood-brain barrier. In this study, we describe that Cn alters the brain endothelium by activating small GTPase RhoA, causing reorganization of the actin cytoskeleton and tight junction modulation to regulate endothelial barrier permeability.

View Article and Find Full Text PDF

spp. has emerged as an opportunistic etiological agent with clinical manifestations varying from localized infections to deep-seated systemic disease. It is also a phytopathogen of economic impact.

View Article and Find Full Text PDF

() is an encapsulated neurotropic fungal pathogen and the causative agent of cryptococcal meningoencephalitis (CME) in humans. Recommended treatment for CME is Amphotericin B (AmpB) and 5-fluorocytosine (5-FC). Though effective, AmpB has displayed numerous adverse side effects due to its potency and nephrotoxicity, prompting investigation into alternative treatments.

View Article and Find Full Text PDF

The encapsulated fungus Cryptococcus neoformans is the most common cause of fungal meningitis, with the highest rate of disease in patients with AIDS or immunosuppression. This microbe enters the human body via inhalation of infectious particles. C.

View Article and Find Full Text PDF

( ) is an encapsulated neurotropic fungal pathogen and the causative agent of cryptococcal meningoencephalitis (CME) in humans. Recommended treatment for CME is Amphotericin B (AmpB) and 5-fluorocytosine (5-FC). Though effective, AmpB has displayed numerous adverse side effects due to its potency and nephrotoxicity, prompting investigation into alternative treatments.

View Article and Find Full Text PDF

Infection of the Central Nervous System (CNS) by the encapsulated fungus Cryptococcus neoformans can lead to high mortality meningitis, most commonly in immunocompromised patients. While the mechanisms by which the fungus crosses the blood-brain barrier to initiate infection in the CNS are well recognized, there are still substantial unanswered questions about the disease progression once the fungus is established in the brain. C.

View Article and Find Full Text PDF
Article Synopsis
  • Infectious diseases account for about 12% of deaths in people with diabetes, with mucormycosis, caused by a specific fungus, being a notable concern due to its high mortality rates and increasing resistance.
  • The rise in global cases of mucormycosis is linked to the higher prevalence of diabetes, which creates an environment that favors the fungal infection.
  • Understanding the pathways and mechanisms of the fungus, including its interaction with the body's immune system, is crucial for developing better antifungal treatments and prevention strategies.
View Article and Find Full Text PDF

Aminoguanidine (AG) inhibits advanced glycation end products (AGEs) and advanced oxidation protein products (AOPP) accumulated as a result of excessive oxidative stress in diabetes. However, the molecular mechanism by which AG reduces AGE-associated damage in diabetes is not well understood. Thus, we investigated whether AG supplementation mitigates oxidative-associated cardiac fibrosis in rats with type 2 diabetes mellitus (T2DM).

View Article and Find Full Text PDF

Background: The protozoan is the causal agent of giardiasis, one of the main diarrheal infections worldwide. Drug resistance to common antigiardial agents and incidence of treatment failures have increased in recent years. Therefore, the search for new molecular targets for drugs against infection is essential.

View Article and Find Full Text PDF

Background: patients with cervical cancer (CC) receiving chemotherapy and radiotherapy have several gastrointestinal adverse effects.

Objective: to evaluate the effect of dietary symbiotic supplementation on fecal calprotectin (FCP), bacterial DNA levels, and gastrointestinal adverse effects in patients with CC.

Methods: clinical, controlled, randomized, double-blind trial.

View Article and Find Full Text PDF

Objectives: This study was undertaken to investigate the amoebicidal potential of curcumin on Entamoeba histolytica, as well as its synergistic effect with metronidazole.

Methods: Entamoeba histolytica trophozoites were exposed to 100, 200 and 300 μm of curcumin, for 6, 12 and 24 h. Consequently, the viability of cells was determined by trypan blue exclusion test.

View Article and Find Full Text PDF

Bilirubin (BR), a metabolite with increased concentrations in plasma during viral hepatitis, has been recognized as a potential immune-modulator. We recently reported that conjugated BR (CB) augments regulatory T cell (Treg) suppressor activity during acute hepatitis A virus (HAV) infection. However, the mechanisms related to the effects of CB on Treg function in the course of hepatotropic viral diseases have not been elucidated.

View Article and Find Full Text PDF

TiO2 nanoparticles used as vectors for the delivery of drugs have shown greater effectiveness. However, TiO2 nanoparticles can cause oxidative stress in liver and kidney, so we analyzed if a previous or simultaneous quercetin treatment could counteract this in rats. Five groups of male Wistar rats (200-250 g) were included: (1) healthy controls, (2) TiO2 group, (3) quercetin group, (4) preventive group: quercetin for 5 days prior to exposure of TiO2, and (5) therapeutic group: TiO2 (5 mg/kg, i.

View Article and Find Full Text PDF